Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
CeriBell, Inc.

CeriBell, Inc. (CBLL) Stock Overview

Explore CeriBell, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CBLL●NASDAQ
HealthcareMedical - Devices
$24.72
$0.15(0.61%)
U.S. Market opens in 57h 43m

CeriBell, Inc. (CBLL)

Meyka AI Score

Z

Key Financials

Market Cap937.9M
P/E Ratio-14.03
EPS (TTM)$-1.76
ROE-0.45%
Fundamental Analysis

AI Price Forecasts

1 Month$24.06
3 Months$28.82
1 Year Target$30.19

CBLL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of CeriBell, Inc. (NASDAQ: CBLL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, CeriBell, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CBLL on the NASDAQ shows an RSI of 70.13, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $30.19 for the NASDAQ listing.

Key metrics behind CeriBell, Inc.'s NASDAQ-traded stock include a P/E ratio of -14.03 and a market capitalization of 937.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CBLL on the NASDAQ.

Price Performance (NASDAQ: CBLL)

1-Day Change
0.61%
5-Day Change
5.64%
1-Month Change
33.48%
3-Month Change
31.84%
6-Month Change
39.11%
Year-to-Date (YTD) Change
12.72%
1-Year Change
100.49%
3-Year Change
-1.12%
5-Year Change
-1.12%
All-Time (Max) Change
-1.12%

Contact Information

https://ceribell.com
800 436 0826
360 North Pastoria Avenue, Sunnyvale, CA, 94085

Company Facts

3,270 Employees
IPO DateOct 11, 2024
CountryUS
Actively Trading

Frequently Asked Questions